GlassScriptPhysician profile
Ravi Diwan
NPI 1376792382
$24,870.19
in general payments reported to CMS, 2019-2025
47 companies · $3,463 in 2025
The $3,463 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,629 · 2020: $2,567 · 2021: $4,391 · 2022: $4,159 · 2023: $3,551 · 2024: $2,111 · 2025: $3,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,125.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,077.61 | 2019-2025 | Mitraclip, Cardiomems, Gallant |
| Janssen Pharmaceuticals, INC | $2,472.42 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $2,084.52 | 2019-2025 | Farxiga, Brilinta, Lynparza |
| Novartis Pharmaceuticals Corporation | $2,050.90 | 2019-2025 | |
| Amgen INC. | $1,697.68 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $1,425.28 | 2021-2025 | Symplicity G3, Abre, Endurant Iis |
| Abiomed | $839.54 | 2020-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $800.49 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $693.66 | 2021-2025 | Verquvo |
| Medtronic Vascular, INC. | $498.77 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $486.96 | 2020-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $464.59 | 2019-2023 | |
| Pfizer INC. | $428.42 | 2019-2025 | |
| Shockwave Medical, INC | $350.98 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $348.23 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $328.69 | 2020-2025 | Nexletol |
| Boston Scientific Corporation | $306.02 | 2019-2025 | Watchman Flx, Avvigo Guidance System |
| Sanofi-Aventis U.S. LLC | $286.35 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $265.09 | 2019-2025 | Lifevest |
| Bridgebio Pharma, INC. | $238.08 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $234.99 | 2023-2025 | Onpattro, Amvuttra |
| Recor Medical INC | $191.61 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cvrx, INC. | $175.97 | 2023-2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $174.75 | 2025 | |
| Inari Medical, INC. | $150.07 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $87.59 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $72.52 | 2021-2023 | Arcalyst |
| Atricure, INC. | $58.90 | 2024-2025 | Atriclip Laa Exclusion System |
| Chiesi USA, INC. | $57.11 | 2021-2023 | Kengreal |
| United Therapeutics Corporation | $52.64 | 2024-2025 | Tyvaso, Tyvaso |
| Kowa Pharmaceuticals America, INC. | $52.39 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $52.18 | 2023-2024 | Inpefa |
| Edwards Lifesciences Corporation | $45.52 | 2025 | Sapien 3 Ultra Resilia |
| Ionis Pharmaceuticals, INC. | $35.64 | 2025 | Tryngolza |
| Terumo Medical Corporation | $33.08 | 2023 | Metacross Otw |
| Inspiremd LTD | $29.55 | 2025 | Cguard Prime Carotid Stent System |
| Kiniksa Pharmaceuticals International, Plc | $27.81 | 2024 | Arcalyst |
| Horizon Therapeutics Plc | $27.05 | 2023 | Krystexxa |
| Imperative Care, INC | $25.96 | 2025 | Symphony Catheter |
| Cardiovascular Systems INC. | $25.65 | 2022 | |
| Cashflow Solutions, LLC | $21.83 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Potrero Medical, INC. | $17.12 | 2023 | |
| Kestra Medical Technology Services, INC. | $15.80 | 2024 | Assure Wcd |
| Vifor Pharma, INC. | $15.77 | 2022 | |
| Globus Medical, INC. | $15.54 | 2025 | Senza |
| Akcea Therapeutics, INC. | $14.54 | 2020 | |
| Lilly USA, LLC | $14.33 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Diwan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.